Clinical experience with the artificial bone graft substitute Calcibon used following curettage of benign and low-grade malignant bone tumors

Scientific Reports
Joerg FriesenbichlerAndreas Leithner

Abstract

Artificial bone graft substitutes, such as Calcibon, are becoming increasingly interesting as they do not cause donor site morbidity which is an advantage compared to autologous bone grafts. The aim of this study was to evaluate the efficacy and potential complications associated with the use of Calcibon. Twenty-seven patients with benign and low-grade malignant bone tumors were treated with curettage and refilling of the bony cavity. Based on the radiological classification system of Neer, these lesions only comprised Grade I lesions, describing cysts that only require curettage and filling, but no additional treatment. At a mean follow up of six months we observed radiological consolidation without resorption of the bone graft substitute. These observations were also made at a mean follow-up of 13 and 32 months, respectively. According to the classification system of Goslings and Gouma we observed six surgical complications. Summing up, Calcibon seems to be a reliable bone graft substitute with low complication rates. However, delayed resorption should be expected. Calcibon seems to be an alternative to autologous bone grafts or allografts in adequate indications.

References

Jan 1, 1989·Journal of Orthopaedic Trauma·E M Younger, M W Chapman
Mar 1, 1997·The Journal of Hospital Infection·A G SutherlandJ D Hutchison
May 10, 2002·Journal of Biomedical Materials Research·E M OomsJ A Jansen
Apr 8, 2003·The Journal of Bone and Joint Surgery. British Volume·Heike WelkerlingReinhard Windhager
Mar 15, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Christian KasperkPeter Nawroth
Jun 3, 2005·Clinical Orthopaedics and Related Research·G H ProsserR J Grimer
Apr 11, 2008·World Journal of Surgery·J C Goslings, D J Gouma
Feb 4, 2011·BMC Musculoskeletal Disorders·Esther M M Van LieshoutPeter Patka
Jul 31, 2012·BMC Musculoskeletal Disorders·Hwan Seong ChoIl Hyung Park
Aug 1, 2012·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·H L YangS S Aiken
Aug 29, 2012·ANZ Journal of Surgery·Luke James Johnson, Mark Clayer
Aug 29, 2012·Orthopaedic Surgery·Bin Liu, Deng-xing Lun
Oct 1, 2013·Clinical Orthopaedics and Related Research·Joerg FriesenbichlerAndreas Leithner
Feb 11, 2014·European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·Gianluca MaestrettiEmmanuel Gautier

❮ Previous
Next ❯

Citations

Mar 7, 2021·Materials·Francesco BainoEnrica Verné
Mar 18, 2021·Bone Research·Jinfeng LiaoZhiyong Qian

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Related Feeds

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.